Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Tobacco IncfiledCriticalJapan Tobacco Inc
Publication of AR095345A1publicationCriticalpatent/AR095345A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Reivindicación 1: Un compuesto representado por la fórmula (1) caracterizado porque n es 1 ó 2, o una de sus sales farmacéuticamente aceptables.Claim 1: A compound represented by the formula (1) characterized in that n is 1 or 2, or a pharmaceutically acceptable salt thereof.
ARP140101049A2013-03-152014-03-14
PIRAZOL-AMIDA COMPOUNDS AND PHARMACEUTICAL USE
AR095345A1
(en)
Compounds derived from pharmaceutically acceptable 2,4-diaminoquinazolines, salts or solvates; pharmaceutical composition comprising them; and use in the treatment of a disorder involving the modulation of tlr7 and / or tlr8.
OPTIONALLY CONDENSED HYDERO-CYCLIC DERIVATIVES OF PIRIDIMINE USEFUL FOR THE TREATMENT OF INFLAMMATORY, METABOLIC, ONCOLOGICAL AND AUTOINMUNITY DISEASES
Compounds derived from benzyl sulfonamide, mogat-2 inhibitors; crystalline compound; pharmaceutical composition; and its use in the treatment of hypertriglyceridemia.